mutations and sophisticated kar yotype. It follows a linear evolution with the CLL clone with the recurrent acquisition of CDKN2AIn the last a long time, the volume of patients referred for allogeneic hematopoietic mobile transplantation has dropped noticeably,133 nevertheless the course of action really should be recommended to young/fit individua